Top executives at Bavarian Nordic, which makes the world’s only monkeypox vaccine, avoided news media in the face of a worldwide shortage of their product. But SIGA, the company behind the antiviral treatment Tecovirimat (TPOXX™), has not been so shy. In an exclusive interview, SIGA’s CEO, Phillip Gomez, says the small, speciality firm is  prepared […] Continue reading ->
The manufacturer of the world’s only vaccine approved for monkeypox, Bavarian Nordic, faces a planned closure of its European production plant until late 2022. With only 16.4 million doses of the MVA-BN vaccine available worldwide, it is unclear how the company plans to meet rising demand for its monkeypox vaccine following the global health emergency […] Continue reading ->